A Placebo-controlled, Double-blind (Sponsor Open), Randomized, Crossover Study to Assess the Efficacy, Safety, and Tolerability of GSK2798745 in Participants With Chronic Cough
Phase of Trial: Phase I/II
Latest Information Update: 23 Jan 2019
At a glance
- Drugs GSK 2798745 (Primary)
- Indications Cough
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 14 Jan 2019 Status changed from active, no longer recruiting to discontinued.
- 11 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated